Recent News
Aspen HIV Prevention Pill Deal Expands African Access
Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.
Dis-Chem Leadership Succession Ends Saltzman Era
The Dis-Chem leadership succession ends as co-founder Ivan Saltzman leaves the board after 48 years, ending the family’s representation.
Extensior Launch Cuts Ozempic Cost By 15%
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
Generic Drug Tariffs Could Raise US Medicine Costs
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.
Medicine Safety Under Scrutiny after iDexis Case
Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring.